色偷偷伊人-色偷偷综合-色无五月-色香蕉影院-色亚洲影院

CANCER IMMUNOLOGY IMMUNOTHERAPY

CANCER IMMUNOLOGY IMMUNOTHERAPY

癌癥免疫學免疫療法

期刊周期:Monthly
研究方向:醫(yī)學
影響因子:4.9
通訊地址:SPRINGER, 233 SPRING ST, NEW YORK, USA, NY, 10013
官網(wǎng):http://www.springer.com/medicine/internal/journal/262
投稿地址:https://www.editorialmanager.com/ciim/default.aspx
審稿速度:平均1月

  中文簡介

自1976年成立以來,腫瘤免疫學、免疫治療(CII)在腫瘤免疫學領域取得了重大進展。該雜志是一個論壇的新概念和進展的基礎,翻譯,臨床癌癥免疫學和免疫治療。CII熱衷于發(fā)表廣泛的觀點和評論,擴展或挑戰(zhàn)現(xiàn)有范式的結果,以及未能復制支持當前范式的實驗的負面研究,以及在不同環(huán)境中成功復制他人結果的論文。除了發(fā)表原創(chuàng)研究論文和評論,CII還提供以下獨特的出版格式:·“聚焦研究綜述”,與會議報告一起發(fā)表,為每位演講者提供了機會來擴展他們在會議上提出的想法和概念。·“書面研討會”,是一系列圍繞某一特定問題并針對該領域有爭議但具有戰(zhàn)略意義的主題的補充論文組成的虛擬研討會,通常由4-8篇論文和召集人的附帶評論組成。CII隸屬于癌癥免疫治療協(xié)會(CIMT)、加拿大癌癥免疫治療協(xié)會(CCIC)、日本癌癥免疫協(xié)會(JACI)、意大利生物腫瘤免疫治療網(wǎng)絡(NIBIT)、免疫腫瘤免疫治療和免疫監(jiān)測協(xié)會(CITIM)。

  英文簡介

Since its inception in 1976, Cancer Immunology, Immunotherapy (CII) has reported significant advances in the field of tumor immunology. The journal serves as a forum for new concepts and advances in basic, translational, and clinical cancer immunology and immunotherapy. CII is keen to publish broad-ranging ideas and reviews, results which extend or challenge established paradigms, as well as negative studies which fail to reproduce experiments that support current paradigms, and papers that do succeed in reproducing others’ results in different contexts.In addition to publishing original research articles and reviews, CII also offers the following unique publication formats:·“Focussed Research Reviews,” published together with a conference meeting report, which provide individual speakers with the opportunity to expand on the ideas and concepts they presented at the conference.·“Symposia-in-Writing,” which are virtual workshops consisting of a series of complimentary papers centered on a specific issue and addressing controversial but strategic topics in the field, usually consisting of 4-8 papers and an accompanying commentary by the convener. CII is affiliated with the Association for Cancer Immunotherapy (CIMT), Canadian Cancer Immunotherapy Consortium (CCIC), The Japanese Association for Cancer Immunology (JACI), Network Italiano per la Bioterapia dei Tumori (NIBIT), Sociedad Espa?ola de Immunologia-Grupo Espa?ol de ImmunoTerapia (SEI-GEIT), and Cancer Immunotherapy & Immunomonitoring (CITIM).

  近年期刊影響因子趨勢圖

  相關醫(yī)學SCI期刊推薦

SCI服務

搜論文知識網(wǎng) 冀ICP備15021333號-3

主站蜘蛛池模板: 国产精品日韩欧美亚洲另类 | 在线欧美日韩国产 | 精品视频麻豆网站 | 国产精品久久久久999 | 一区亚洲 | 国产jav| 97碰碰碰免费公开在线视频 | 1313午夜精品美女爱做视频 | 在线看的网站 | 免费啪视频一区二区三区 | 国产乱码精品一区二区三区中 | www.久久精品视频 | 激情婷婷在线 | 久久久久日韩精品免费观看网 | 日本高清不卡一区久久精品 | 黄色avav| 午夜久久久久久网站 | 老司机成人福利视频在线观看免费 | 久久精品第一页 | 亚洲一区播放 | 干成人网 | 粉嫩国产精品14xxxxx | 免费看av在线网站网址 | 99久久综合狠狠综合久久 | 国产精品国产三级在线专区 | 1024视频在线观看国产成人 | 亚洲美女色成人综合 | 目韩一区二区三区系列片丶 | 欧美国产日韩精品 | 国产在线拍国产拍拍偷 | 国产在线拍偷自揄观看视频网站 | 亚洲日本高清影院毛片 | 黄色三级视频片 | 国产影视精选网站 | 成人区在线观看免费视频 | 国产精品99爱免费视频 | 国产综合精品一区二区 | 俺来也俺来也天天夜夜视频 | 亚洲国产美女精品久久久久 | 诱人的女邻居bd中文字幕 | 99亚洲乱人伦精品 |